Champions Oncology
CSBR
12 hedge funds and large institutions have $11.5M invested in Champions Oncology in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 9 → 12 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less capital invested
Capital invested by funds: $18.7M → $11.5M (-$7.17M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$786K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$37.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.07K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
PAR Capital Management
Boston,
Massachusetts
|
-$114K |
| 2 |
Morgan Stanley
New York
|
-$428 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BPI
1
Battery Partners IX
Boston,
Massachusetts
| $4.2M | – | – | – |
|
|
NMC
2
NEA Management Company
Timonium,
Maryland
| $3.36M | – | – | – |
|
|
PCM
3
PAR Capital Management
Boston,
Massachusetts
| $1.71M | -$114K | -36,433 | -4% |
|
|
SM
4
Sabby Management
Miami Beach,
Florida
| $1.18M | +$786K | +251,400 | +85% |
|
|
PA
5
Perceptive Advisors
New York
| $801K | – | – | – |
|
|
KCM
6
Knoll Capital Management
Miami,
Florida
| $239K | – | – | – |
|
|
BRWA
7
B. Riley Wealth Advisors
Boca Raton,
Florida
| $26K | +$37.5K | +11,988 | New |
|
|
SSB
8
Sandy Spring Bank
Olney,
Maryland
| $18K | – | – | – |
|
|
9
Morgan Stanley
New York
| $6K | -$428 | -137 | -5% |
|
10
Bank of America
Charlotte,
North Carolina
| $4K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $3K | +$5.07K | +1,622 | New |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $1K | +$1.53K | +488 | New |
|
CSBR Hedge Fund Activity: Q2 2016 in Review
12 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2016, worth a combined $11.5M — down 38% from $18.7M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CSBR positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Sabby Management, adding an estimated $786K. The largest seller was PAR Capital Management, cutting an estimated $114K.
- 12 institutional investors held Champions Oncology (CSBR) as of Q2 2016, up from 9 in Q1 2016.
- Funds reported $11.5M of Champions Oncology stock for Q2 2016, down 38% quarter-over-quarter.
- 3 funds opened new Champions Oncology positions in Q2 2016 and 0 closed out, a net change of +3 holders.
- The largest Champions Oncology buyer in Q2 2016 was Sabby Management, an estimated $786K added.
- The largest Champions Oncology seller in Q2 2016 was PAR Capital Management, an estimated $114K sold.
Based on aggregated 13F filings for Q2 2016.